Mehmet Ulug
Research Subjects
Mehmet Ulug has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
- Mustafa Kemal Çelen
Infectious Diseases and Clinical Microbiology, Dicle University, Diyarbakir, Turkey, Turkey (Türkiye)
8 shared publications - Celal Ayaz
Dicle University Medical School, Diyarbakir, Turkey
7 shared publications - Ercan Gedik
Dicle University Medical School, Diyarbakir, Turkey
4 shared publications - Sadullah Girgin
Dicle University Medical School, Diyarbakir, Turkey
4 shared publications Celal Ayaz
Dicle University Medical School, Department of Infectious Diseases and Clinical Microbiology, 21280 Diyarbakir, Turkey
3 shared publications- Salih Hosoglu
Department of Infectious Diseases, Dicle University Hospital, Diyarbakir, Turkey
3 shared publications
Latest Publications
- Open Access
- 3 November 2016
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 14 (1) , 1-10
Quality of life and related factors among chronic hepatitis B-infected patients: a multi-center study, Turkey
The aim of this study was to assess health-related quality of life (HRQOL) among chronic hepatitis B (CHB) patients in Turkey and to study related factors. This multicenter study was carried out between January 01 and April 15, 2015 in Turkey in 57 centers. Adults were enrolled and studied in three groups. Group 1: Inactive HBsAg carriers, Group 2: CHB patients receiving antiviral therapy, Group 3: CHB patients who were neither receiving antiviral therapy nor were inactive HBsAg carriers. Study data was collected by face-to-face interviews using a standardized questionnaire, Short Form-36 (SF-36) and Hepatitis B Quality of Life (HBQOL). Values equivalent to p < 0.05 in analyses were accepted as statistically significant. Four thousand two hundred fifty-seven patients with CHB were included in the study. Two thousand five hundred fifty-nine (60.1 %) of the patients were males. Groups 1, 2 and 3, consisted of 1529 (35.9 %), 1721 (40.4 %) and 1007 (23.7 %) patients, respectively. The highest value of HRQOL was found in inactive HBsAg carriers. We found that total HBQOL score increased when antiviral treatment was used. However, HRQOL of CHB patients varied according to their socio-demographic properties. Regarding total HBQOL score, a higher significant level of HRQOL was determined in inactive HBV patients when matched controls with the associated factors were provided. The HRQOL score of CHB patients was higher than expected and it can be worsen when the disease becomes active. Use of an antiviral therapy can contribute to increasing HRQOL of patients.
- 3 November 2016
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 14 (1) , 1-10
Open AccessQuality of life and related factors among chronic hepatitis B-infected patients: a multi-center study, Turkey
The aim of this study was to assess health-related quality of life (HRQOL) among chronic hepatitis B (CHB) patients in Turkey and to study related factors. This multicenter study was carried out between January 01 and April 15, 2015 in Turkey in 57 centers. Adults were enrolled and studied in three groups. Group 1: Inactive HBsAg carriers, Group 2: CHB patients receiving antiviral therapy, Group 3: CHB patients who were neither receiving antiviral therapy nor were inactive HBsAg carriers. Study data was collected by face-to-face interviews using a standardized questionnaire, Short Form-36 (SF-36) and Hepatitis B Quality of Life (HBQOL). Values equivalent to p < 0.05 in analyses were accepted as statistically significant. Four thousand two hundred fifty-seven patients with CHB were included in the study. Two thousand five hundred fifty-nine (60.1 %) of the patients were males. Groups 1, 2 and 3, consisted of 1529 (35.9 %), 1721 (40.4 %) and 1007 (23.7 %) patients, respectively. The highest value of HRQOL was found in inactive HBsAg carriers. We found that total HBQOL score increased when antiviral treatment was used. However, HRQOL of CHB patients varied according to their socio-demographic properties. Regarding total HBQOL score, a higher significant level of HRQOL was determined in inactive HBV patients when matched controls with the associated factors were provided. The HRQOL score of CHB patients was higher than expected and it can be worsen when the disease becomes active. Use of an antiviral therapy can contribute to increasing HRQOL of patients.
- Open Access
- 1 January 2012
- Published by Hindawi Limited in Canadian Journal of Infectious Diseases and Medical Microbiology
- Vol. 23 (1) , e13-e15
Pulmonary Involvement in Brucellosis
BACKGROUND: Brucellosis is a zoonotic disease caused by a Gram-negative bacillus of theBrucellagenus with multisystem involvement, primarily affecting the reticuloendothelial system, joints, heart and kidneys. Although the disease can be spread by inhalation, pulmonary involvement is rare.OBJECTIVE: To report a case of brucellosis with pulmonary involvement.CASE PRESENTAION: A previously healthy 36-year-old woman was admitted with complaints of fever, weakness, night sweats, dry cough and bilateral chest pain. She hed been diagnosed with pneumonia 20 days previously and was started on a course of ampicillin for 14 days, with no response. Her chest auscultation revealed diminished breath sounds and scattered crackles and rhonchi over the inferior zone of the right hemithorax. Wright and Coombs testing resulted in titres of 1:1280 and 1:640, respectively. Chest radiography revealed an area of confluent lobar consolidation in the right lower lobe. Treatment was started with a six-week course of oral doxycycline 200 mg/day and rifampicin 600 mg/day. This treatment regimen rapidly improved the patient’s condition. Follow-up after one year showed no residual effects from the infection.CONCLUSION: Pulmonary involvement is a rare event in the course of brucellosis, but the rate could be higher than currently estimated. In endemic regions, brucellosis should be considered as a causative agent in patients with pulmonary symptoms.
- 1 January 2012
- Published by Hindawi Limited in Canadian Journal of Infectious Diseases and Medical Microbiology
- Vol. 23 (1) , e13-e15
Open AccessPulmonary Involvement in Brucellosis
BACKGROUND: Brucellosis is a zoonotic disease caused by a Gram-negative bacillus of theBrucellagenus with multisystem involvement, primarily affecting the reticuloendothelial system, joints, heart and kidneys. Although the disease can be spread by inhalation, pulmonary involvement is rare.OBJECTIVE: To report a case of brucellosis with pulmonary involvement.CASE PRESENTAION: A previously healthy 36-year-old woman was admitted with complaints of fever, weakness, night sweats, dry cough and bilateral chest pain. She hed been diagnosed with pneumonia 20 days previously and was started on a course of ampicillin for 14 days, with no response. Her chest auscultation revealed diminished breath sounds and scattered crackles and rhonchi over the inferior zone of the right hemithorax. Wright and Coombs testing resulted in titres of 1:1280 and 1:640, respectively. Chest radiography revealed an area of confluent lobar consolidation in the right lower lobe. Treatment was started with a six-week course of oral doxycycline 200 mg/day and rifampicin 600 mg/day. This treatment regimen rapidly improved the patient’s condition. Follow-up after one year showed no residual effects from the infection.CONCLUSION: Pulmonary involvement is a rare event in the course of brucellosis, but the rate could be higher than currently estimated. In endemic regions, brucellosis should be considered as a causative agent in patients with pulmonary symptoms.
- Open Access
- 5 December 2011
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 5 (12) , 896-900
A case report and literature review: osteomyelitis caused by community-associated methicillin resistant Staphylococcus aureus.
Osteomyelitis in adolescents is a serious disease with the potential for lifelong disability. The key to successful management is early diagnosis, including bone sampling for microbiological and pathological examination to allow targeted and long-lasting antibiotic therapy. Staphylococcus aureus is the most frequently isolated microorganism in these patients. Methicillin-resistant S. aureus (MRSA) is usually considered a nosocomial pathogen, but increasingly it is acquired in the community. We present a case of acute osteomyelitis caused by community-associated MRSA (CA-MRSA) who had never been hospitalized and had no other known risk factors for MRSA. The changing epidemiology of MRSA became evident when infections occurred in previously healthy patients without established risk factors. MRSA infections have been increasingly reported in pediatric patients, but they are uncommon in adults. Skin and soft tissue infections remain the most common manifestations of CA-MRSA infections. Glycopeptides can be used as initial therapy and oral trimetoprim-sulfamethoxazole as sequential therapy for these patients.
- 5 December 2011
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 5 (12) , 896-900
Open AccessA case report and literature review: osteomyelitis caused by community-associated methicillin resistant Staphylococcus aureus.
Osteomyelitis in adolescents is a serious disease with the potential for lifelong disability. The key to successful management is early diagnosis, including bone sampling for microbiological and pathological examination to allow targeted and long-lasting antibiotic therapy. Staphylococcus aureus is the most frequently isolated microorganism in these patients. Methicillin-resistant S. aureus (MRSA) is usually considered a nosocomial pathogen, but increasingly it is acquired in the community. We present a case of acute osteomyelitis caused by community-associated MRSA (CA-MRSA) who had never been hospitalized and had no other known risk factors for MRSA. The changing epidemiology of MRSA became evident when infections occurred in previously healthy patients without established risk factors. MRSA infections have been increasingly reported in pediatric patients, but they are uncommon in adults. Skin and soft tissue infections remain the most common manifestations of CA-MRSA infections. Glycopeptides can be used as initial therapy and oral trimetoprim-sulfamethoxazole as sequential therapy for these patients.
- Open Access
- 1 August 2011
- Published by FapUNIFESP (SciELO) in The Brazilian Journal of Infectious Diseases
- Vol. 15 (4) , 406-407
Unusual clinical presentations of brucellosis in childhood
- 1 August 2011
- Published by FapUNIFESP (SciELO) in The Brazilian Journal of Infectious Diseases
- Vol. 15 (4) , 406-407
Open AccessUnusual clinical presentations of brucellosis in childhood
- Open Access
- 1 December 2010
- Published by FapUNIFESP (SciELO) in The Brazilian Journal of Infectious Diseases
- Vol. 14 (6) , 641-642
An unusual presentation of brucellosis: acute hepatitis
- 1 December 2010
- Published by FapUNIFESP (SciELO) in The Brazilian Journal of Infectious Diseases
- Vol. 14 (6) , 641-642
Open AccessAn unusual presentation of brucellosis: acute hepatitis
- 1 December 2010
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 23 (3) , 89-94
Evaluation of 78 Cases with Brucellosis
- 1 December 2010
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 23 (3) , 89-94
Evaluation of 78 Cases with Brucellosis
- Open Access
- 26 October 2010
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 4 (10) , 668-673
Acute hepatitis: a rare complication of Epstein-Barr virus (EBV) infection
Infectious Mononucleosis (IM), a benign lymphoproliferative disease, is the best known clinical syndrome caused by Epstein-Barr Virus (EBV). It usually resolves over a period of weeks or months without sequelae but may occasionally be complicated by a wide variety of neurologic, hematologic, hepatic, respiratory, and psychological complications. In this report we describe a patient with acute hepatitis following EBV-IM in a previously healthy woman. A 26-year-old woman who presented with fever, generalized weakness, nausea, sore throat, yellowing of skin, and a generalized skin rash was admitted to our clinic. Tonsillar enlargement, pharyngeal erythema, palatal petechiae, lymphadenopathy, and jaundice were noted. Significant atypical lymphocytes ( > 10%) were seen on the peripheral blood smear. Liver function tests such as ALT: 303 U/L, AST: 172 U/L, ALP: 193 U/L and total bilirubin: 7.3 mg/dl were elevated. Serological tests for EBV infection were consistent with acute infection (EBV virus capsid antigen was reactive with IgM and IgG antibodies). The Monospot test was also positive. On the seventh day, liver function tests and bilirubin had risen to peak level and platelets were decreased. The patient was managed supportively and her critical condition improved and was finally stabilized. Although the prognosis for IM is very favorable, a variety of acute complications may occur.
- 26 October 2010
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 4 (10) , 668-673
Open AccessAcute hepatitis: a rare complication of Epstein-Barr virus (EBV) infection
Infectious Mononucleosis (IM), a benign lymphoproliferative disease, is the best known clinical syndrome caused by Epstein-Barr Virus (EBV). It usually resolves over a period of weeks or months without sequelae but may occasionally be complicated by a wide variety of neurologic, hematologic, hepatic, respiratory, and psychological complications. In this report we describe a patient with acute hepatitis following EBV-IM in a previously healthy woman. A 26-year-old woman who presented with fever, generalized weakness, nausea, sore throat, yellowing of skin, and a generalized skin rash was admitted to our clinic. Tonsillar enlargement, pharyngeal erythema, palatal petechiae, lymphadenopathy, and jaundice were noted. Significant atypical lymphocytes ( > 10%) were seen on the peripheral blood smear. Liver function tests such as ALT: 303 U/L, AST: 172 U/L, ALP: 193 U/L and total bilirubin: 7.3 mg/dl were elevated. Serological tests for EBV infection were consistent with acute infection (EBV virus capsid antigen was reactive with IgM and IgG antibodies). The Monospot test was also positive. On the seventh day, liver function tests and bilirubin had risen to peak level and platelets were decreased. The patient was managed supportively and her critical condition improved and was finally stabilized. Although the prognosis for IM is very favorable, a variety of acute complications may occur.
- 14 September 2010
- Vol. 14 (3) , 218
Pyogenic liver abscess caused by community-acquired multidrug resistance Pseudomonas aeruginosa.
- 14 September 2010
- Vol. 14 (3) , 218
Pyogenic liver abscess caused by community-acquired multidrug resistance Pseudomonas aeruginosa.